CYP2D6 and myopathy: The association between CYP2D6 and atorvastatin-induced myopathy was significant in both discovery and validation cohorts [21], but since it is unclear whether CYP2D6 contributes to atorvastatin metabolism, mechanistic studies will be necessary before clinical translation could be considered.